DJIA 17,637.40 -35.20 -0.20%
NASDAQ 4,754.38 -3.50 -0.07%
S&P 500 2,050.06 -1.76 -0.09%
market minute promo

BioMarin Pharmaceuticals (NASDAQ: BMRN)

100.03 2.34 (2.40%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BMRN $100.03 2.40%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $98.09
Previous Close $97.69
Daily Range $97.50 - $100.48
52-Week Range $55.04 - $100.50
Market Cap $14.8B
P/E Ratio -111.01
Dividend (Yield) $0.00 (0.0%)
Volume 596,163
Average Daily Volume 1,372,490
Current FY EPS -$1.05





BioMarin Pharmaceuticals (BMRN) Description

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. Website:

News & Commentary

Forget Marijuana Stocks: Here Are 3 Smarter Investments

Three Motley Fool contributors offer up investing ideas that may be smarter than investing in marijuana.

'Mad Money' Lightning Round: Constellation Brands the New King in Town

BioMarin to Raise Funds to Finance Prosensa Acquisition - Analyst Blog

Health Care Sector Update for 01/22/2015: SHPG, NNVC, BMRN

Today's Post-Market Laggard Is Biomarin Pharmaceutical (BMRN)

State of the Union Address Investing Idea: Precision Medicine

There are plenty of companies developing precision medicine drugs already, and investors would be wise to watch key players.

State Of The Union Lights Up Biotech

8 Biotech Stock Controversies Emerging From 'JPM15' Conference

3 Warning Signs You've Invested in a Dangerous Biotech Stock

Three Motley Fool analysts help investors spot biotech stock warning signals.

Nomura Analyst Sees Fast Growth At BioMarin Pharmaceutical

See More BMRN News...

BMRN's Top Competitors

BMRN $100.03 (2.40%)
Current stock: BMRN
AMGN $160.66 (0.53%)
Current stock: AMGN
GILD $107.03 (1.41%)
Current stock: GILD
BIIB $361.30 (1.05%)
Current stock: BIIB